CongressBuys

Rep. Jonathan L. Jackson sold Regeneron Pharmaceuticals (REGN)

Rep. Jonathan L. Jackson (D-IL-1) · $15K–$50K · traded Nov 13, 2024

Transaction
Sold (full)
Amount
$15K–$50K
Owner
Joint
Traded
Nov 13, 2024
Disclosed
Dec 12, 2024
Days to disclose
29
Asset type
Stock
As filed
Regeneron Pharmaceuticals, Inc. - Common Stock
Industry
Biotechnology · Healthcare

Other trades in this filing

Recent Congress trades in REGN

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.